rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2003-8-29
|
pubmed:abstractText |
The metabolic syndrome is a cluster of clinical characteristics thought to be associated with increased coronary risk. This analysis evaluates angiographic progression of coronary disease in women who are postmenopausal with and without the metabolic syndrome enrolled in the Women's Angiographic Vitamin & Estrogen (WAVE) trial, a randomized, controlled trial of hormone therapy and antioxidant vitamins.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1097-6744
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
146
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
439-45
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12947360-Aged,
pubmed-meshheading:12947360-Anticholesteremic Agents,
pubmed-meshheading:12947360-Coronary Angiography,
pubmed-meshheading:12947360-Coronary Disease,
pubmed-meshheading:12947360-Disease Progression,
pubmed-meshheading:12947360-Female,
pubmed-meshheading:12947360-Humans,
pubmed-meshheading:12947360-Metabolic Syndrome X,
pubmed-meshheading:12947360-Middle Aged,
pubmed-meshheading:12947360-Multivariate Analysis,
pubmed-meshheading:12947360-Postmenopause,
pubmed-meshheading:12947360-Regression Analysis
|
pubmed:year |
2003
|
pubmed:articleTitle |
Metabolic syndrome and coronary angiographic disease progression: the Women's Angiographic Vitamin & Estrogen trial.
|
pubmed:affiliation |
Department of Medicine, George Washington University, Washington, DC, USA. jhsia@mfa.gwu.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Multicenter Study
|